Related Experiment Videos
Cardiac transplantation: indications, procurement, operation, and management
Heart & Lung : the Journal of Critical Care
|September 1, 1985
Summary
Cardiac transplant survival rates improved significantly by 1984 due to strict donor/recipient selection, perioperative care, and the introduction of cyclosporine. Long-term evaluation is needed for cyclosporine
Area of Science:
- Cardiology
- Immunosuppression Therapy
Background:
- Cardiac transplantation is a critical treatment for end-stage heart failure.
- Improving patient survival post-transplant remains a key clinical challenge.
Purpose of the Study:
- To evaluate the survival rates and outcomes of cardiac transplantations performed between 1982 and 1984.
- To identify factors contributing to improved survival in cardiac transplant recipients.
Main Methods:
- Analysis of 22 cardiac transplantations performed at the Texas Heart Institute.
- Cumulative follow-up of 188 patient-months.
- Inclusion of endomyocardial biopsy in perioperative management.
Main Results:
- Actuarial survival rate at 20 months reached 72%.
- Key contributing factors include strict donor/recipient selection and perioperative care.
- Introduction of cyclosporine as a primary immunosuppressant.
Conclusions:
- Cyclosporine, combined with rigorous selection and perioperative management, significantly enhanced cardiac transplant survival rates.
- Long-term monitoring is essential to assess cyclosporine's efficacy and manage potential complications like hypertension and myocardial fibrosis.